Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 277

1.

Implementation of intermittent preventive treatment in pregnancy with sulphadoxine/pyrimethamine (IPTp-SP) at a district health centre in rural Senegal.

Olliaro PL, Delenne H, Cisse M, Badiane M, Olliaro A, Vaillant M, Brasseur P.

Malar J. 2008 Nov 7;7:234. doi: 10.1186/1475-2875-7-234.

2.

Malaria prevention during pregnancy: assessing the disease burden one year after implementing a program of intermittent preventive treatment in Koupela District, Burkina Faso.

Sirima SB, Cotte AH, Konaté A, Moran AC, Asamoa K, Bougouma EC, Diarra A, Ouédraogo A, Parise ME, Newman RD.

Am J Trop Med Hyg. 2006 Aug;75(2):205-11.

PMID:
16896120
3.

An evaluation of the effects of intermittent sulfadoxine-pyrimethamine treatment in pregnancy on parasite clearance and risk of low birthweight in rural Malawi.

Verhoeff FH, Brabin BJ, Chimsuku L, Kazembe P, Russell WB, Broadhead RL.

Ann Trop Med Parasitol. 1998 Mar;92(2):141-50.

PMID:
9625909
4.

Decline of placental malaria in southern Ghana after the implementation of intermittent preventive treatment in pregnancy.

Hommerich L, von Oertzen C, Bedu-Addo G, Holmberg V, Acquah PA, Eggelte TA, Bienzle U, Mockenhaupt FP.

Malar J. 2007 Nov 8;6:144.

5.

The effect of health care worker training on the use of intermittent preventive treatment for malaria in pregnancy in rural western Kenya.

Ouma PO, Van Eijk AM, Hamel MJ, Sikuku E, Odhiambo F, Munguti K, Ayisi JG, Kager PA, Slutsker L.

Trop Med Int Health. 2007 Aug;12(8):953-61.

6.

Antimalarials during pregnancy: a cost-effectiveness analysis.

Schultz LJ, Steketee RW, Chitsulo L, Wirima JJ.

Bull World Health Organ. 1995;73(2):207-14.

7.

Randomized trial of 2-dose versus monthly sulfadoxine-pyrimethamine intermittent preventive treatment for malaria in HIV-positive and HIV-negative pregnant women in Malawi.

Filler SJ, Kazembe P, Thigpen M, Macheso A, Parise ME, Newman RD, Steketee RW, Hamel M.

J Infect Dis. 2006 Aug 1;194(3):286-93. Epub 2006 Jun 20.

PMID:
16826475
8.

Antenatal receipt of sulfadoxine-pyrimethamine does not exacerbate pregnancy-associated malaria despite the expansion of drug-resistant Plasmodium falciparum: clinical outcomes from the QuEERPAM study.

Taylor SM, Antonia AL, Chaluluka E, Mwapasa V, Feng G, Molyneux ME, ter Kuile FO, Meshnick SR, Rogerson SJ.

Clin Infect Dis. 2012 Jul;55(1):42-50. doi: 10.1093/cid/cis301. Epub 2012 Mar 22.

9.

A randomized, controlled trial of intermittent preventive treatment with sulfadoxine-pyrimethamine, amodiaquine, or the combination in pregnant women in Ghana.

Clerk CA, Bruce J, Affipunguh PK, Mensah N, Hodgson A, Greenwood B, Chandramohan D.

J Infect Dis. 2008 Oct 15;198(8):1202-11. doi: 10.1086/591944.

PMID:
18752443
10.
11.

Sulfadoxine-pyrimethamine resistance and intermittent preventive treatment during pregnancy: a retrospective analysis of birth weight data in the Democratic Republic of Congo (DRC).

Likwela JL, D'Alessandro U, Lokwa BL, Meuris S, Dramaix MW.

Trop Med Int Health. 2012 Mar;17(3):322-9. doi: 10.1111/j.1365-3156.2011.02935.x. Epub 2011 Dec 30.

12.

Implementation of intermittent preventive treatment with sulphadoxine-pyrimethamine for control of malaria in pregnancy in Kisumu, western Kenya.

van Eijk AM, Ayisi JG, ter Kuile FO, Slutsker L, Otieno JA, Misore AO, Odondi JO, Rosen DH, Kager PA, Steketee RW, Nahlen BL.

Trop Med Int Health. 2004 May;9(5):630-7.

13.

Individual efficacy of intermittent preventive treatment with sulfadoxine-pyrimethamine in primi- and secundigravidae in rural Burkina Faso: impact on parasitaemia, anaemia and birth weight.

Gies S, Coulibaly SO, Ouattara FT, D'Alessandro U.

Trop Med Int Health. 2009 Feb;14(2):174-82. doi: 10.1111/j.1365-3156.2008.02215.x. Epub 2009 Jan 16.

14.

Antenatal care visit attendance, intermittent preventive treatment and bed net use during pregnancy in Gabon.

Bouyou-Akotet MK, Mawili-Mboumba DP, Kombila M.

BMC Pregnancy Childbirth. 2013 Feb 26;13:52. doi: 10.1186/1471-2393-13-52.

15.

A community effectiveness trial of strategies promoting intermittent preventive treatment with sulphadoxine-pyrimethamine in pregnant women in rural Burkina Faso.

Gies S, Coulibaly SO, Ouattara FT, Ky C, Brabin BJ, D'Alessandro U.

Malar J. 2008 Sep 18;7:180. doi: 10.1186/1475-2875-7-180.

16.

Two-dose versus monthly intermittent preventive treatment of malaria with sulfadoxine-pyrimethamine in HIV-seropositive pregnant Zambian women.

Hamer DH, Mwanakasale V, Macleod WB, Chalwe V, Mukwamataba D, Champo D, Mwananyanda L, Chilengi R, Mubikayi L, Mulele CK, Mulenga M, Thea DM, Gill CJ.

J Infect Dis. 2007 Dec 1;196(11):1585-94. Epub 2007 Oct 25.

PMID:
18008241
17.

Intermittent preventive treatment of malaria with sulphadoxine-pyrimethamine during pregnancy in Burkina Faso: effect of adding a third dose to the standard two-dose regimen on low birth weight, anaemia and pregnancy outcomes.

Valea I, Tinto H, Drabo MK, Huybregts L, Henry MC, Roberfroid D, Guiguemde RT, Kolsteren P, D'Alessandro U; FSP/MISAME study Group.

Malar J. 2010 Nov 12;9:324. doi: 10.1186/1475-2875-9-324.

18.

Evaluation of sulphadoxine-pyrimethamine for intermittent preventive treatment of malaria in pregnancy: a retrospective birth outcomes study in Mansa, Zambia.

Mace KE, Chalwe V, Katalenich BL, Nambozi M, Mubikayi L, Mulele CK, Wiegand RE, Filler SJ, Kamuliwo M, Craig AS, Tan KR.

Malar J. 2015 Feb 7;14:69. doi: 10.1186/s12936-015-0576-8.

19.

Supplemental Content

Support Center